Valuation & Metrics
YTD Performance:
+41.41%
28D Momentum:
+0.05%
Regression Slope:
0.0
7D Projection:
109.34
7D Expected Range:
109.24 - 109.44
Signal Reliability:
50%
Based on data alignment, market sentiment and historical volatility
Executive Summary
- Aspen Pharmacare trading at 159.88 ZAR with +6.3% momentum over 28 days—solid upward trend in healthcare sector.
- South African pharma benefits from local healthcare demand and regional export reach, but faces Rand volatility and power supply risks.
- For local businesses: stable healthcare spending supports Aspen; monitor Eskom disruptions and Rand weakness as key headwinds.
Price Performance (28-Day Trend)
Intelligence Matrix
🚢 Logistics & Supply
Transnet rail delays and port congestion risk pharma export timelines; domestic distribution relies on road networks vulnerable to load-shedding.
🌍 Origin Insight
South Africa's pharma hub status supports Aspen's regional footprint; local manufacturing and API sourcing reduce import dependency versus peers.
⚖️ Regulatory Shift
SARB rate environment (currently restrictive) pressures input costs; healthcare price controls and medicine registration timelines remain structural headwinds.
📊 Price Trend
Current price 159.88 ZAR (+6.3% in 28 days) signals investor confidence; Rand strength would boost export margins, but currency weakness remains tail risk.